Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol for Emergence Agitation in FESS
NCT03398759Unknown
- Sponsor
- Renji Hospital
- Start
- Feb 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Emergence agitation (EA) comparing Butorphanol with Placebo (2 arms). Primary endpoint: Emergence agitation incidence at 1 hour. Status: unknown.
02
Drugs
butorphanol
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT03398759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03398759.